We now know that immune cells – not only in the body’s periphery but especially in the brain – can produce autoantibodies that cause severe neurological and psychiatric diseases. Founded to explore the latest discoveries in autoimmune neuropsychiatry, Arialys Therapeutics is developing new precision medicines to specifically block pathogenic autoantibodies in the brain and meaningfully expand the treatment possibilities for neuropsychiatric disorders driven by autoimmune disease.
Company Details
- Employees
- 20
- Address
- 11099 North Torrey Pines Rd Suite 290, La Jolla,california 92037,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- in running global clinical studies.
- HQ
- La Jolla, California
Arialys Therapeutics Questions
Arialys Therapeutics's LinkedIn profile is https://www.linkedin.com/company/arialys-therapeutics
Arialys Therapeutics has
20 employees.
View email and phone details for 20
employees at Arialys Therapeutics.
Arialys Therapeutics's industry is
Pharmaceutical Manufacturing
Arialys Therapeutics's top competitors are
Star Therapeutics,
Arrivo Bio,
Apollo Therapeutics,
Tentarix Biotherapeutics,
Avalon Bioventures,
Neurocrine Biosciences,
Nimbus Therapeutics,
Enlaza Therapeutics,
Actio Biosciences, Inc.,
Artiva Biotherapeutics.
Arialys Therapeutics's categories are Pharmaceutical Manufacturing
